8-KEarnings & ResultsExhibits & Filings

JOHNSON & JOHNSON 8-K Report, Financial Results (Jul 18, 2006)

Filed July 18, 2006For Securities:JNJ

Summary

Johnson & Johnson (JNJ) filed an 8-K on July 18, 2006, to report its second-quarter financial results for the period ending July 2, 2006. The report primarily serves to disseminate the company's sales and earnings performance for the quarter, providing investors with key financial metrics. This filing is crucial for stakeholders to assess the company's operational and financial health during this period. Investors should focus on the disclosed sales and earnings figures to understand J&J's performance trajectory. The accompanying press release and supplementary financial data offer a detailed look at the company's revenue generation and profitability. This information is essential for evaluating the company's standing within its various business segments and its overall market competitiveness.

Key Highlights

  • 1Filing of Form 8-K on July 18, 2006, reporting on the second quarter ended July 2, 2006.
  • 2Announcement of Johnson & Johnson's sales and earnings for the second quarter.
  • 3Inclusion of an attached press release detailing the quarterly financial results.
  • 4Incorporation of unaudited comparative supplementary sales data.
  • 5Inclusion of a condensed consolidated statement of earnings for the second quarter.
  • 6Stephen J. Cosgrove, Chief Accounting Officer, signed the report.
  • 7The filing is specifically under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report Johnson & Johnson's sales and earnings results for the second quarter of 2006, which ended on July 2, 2006.

The filing includes an attached press release that announces the company's sales and earnings for the quarter, as well as unaudited comparative supplementary sales data and a condensed consolidated statement of earnings.

The report was signed by Stephen J. Cosgrove, who is the Chief Accounting Officer of Johnson & Johnson.

The detailed financial performance data is available in the exhibits attached to this 8-K filing, specifically the press release dated July 18, 2006, and the unaudited comparative supplementary sales data and condensed consolidated statement of earnings for the second quarter.